Next Article in Journal
Activation-induced Markers Detect Vaccine-Specific CD4+ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials
Next Article in Special Issue
Cytokines IL-17, TNF and IFN-γ Alter the Expression of Antimicrobial Peptides and Proteins Disparately: A Targeted Proteomics Analysis using SOMAscan Technology
Previous Article in Journal
Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress
Previous Article in Special Issue
Effects of LL-37 on Gingival Fibroblasts: A Role in Periodontal Tissue Remodeling?
Review

Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases

1
Department of Pulmonology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands
2
Department of Pediatric Pulmonology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht 3508 AB, The Netherlands
3
Regenerative Medicine Center, University Medical Center Utrecht, Utrecht 3508 AB, The Netherlands
4
Research Group Microbiology and Systems Biology, TNO (The Netherlands Organization for Applied Scientific Research), Zeist 3704 HE, The Netherlands
5
Department of Preventive Dentistry, Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam, Amsterdam 1008 AA, The Netherlands
6
Emulate Inc., Boston, MA 02210, USA
*
Author to whom correspondence should be addressed.
Vaccines 2018, 6(3), 49; https://doi.org/10.3390/vaccines6030049
Received: 6 July 2018 / Revised: 23 July 2018 / Accepted: 25 July 2018 / Published: 28 July 2018
The respiratory tract harbours a variety of microorganisms, collectively called the respiratory microbiota. Over the past few years, alterations in respiratory and gut microbiota composition have been associated with chronic inflammatory diseases of the lungs. How these changes influence disease development and progression is an active field of investigation. Identifying and understanding host-microbiota interactions and factors contributing to these interactions could promote the development of novel therapeutic strategies aimed at restoring host-microbiota homeostasis. In this review, we discuss recent literature on host-microbiota interactions in the respiratory tract, with a specific focus on the influence of endogenous host defence peptides and proteins (HDPs) on the composition of microbiota populations in vivo and explore possible HDPs-related therapeutic approaches targeting microbiota dysbiosis in chronic inflammatory lung diseases. View Full-Text
Keywords: chronic inflammatory lung diseases; COPD; Asthma; cystic fibrosis; microbiota; host defence peptides; host-microbiota interactions chronic inflammatory lung diseases; COPD; Asthma; cystic fibrosis; microbiota; host defence peptides; host-microbiota interactions
Show Figures

Figure 1

MDPI and ACS Style

Van der Does, A.M.; Amatngalim, G.D.; Keijser, B.; Hiemstra, P.S.; Villenave, R. Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases. Vaccines 2018, 6, 49. https://doi.org/10.3390/vaccines6030049

AMA Style

Van der Does AM, Amatngalim GD, Keijser B, Hiemstra PS, Villenave R. Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases. Vaccines. 2018; 6(3):49. https://doi.org/10.3390/vaccines6030049

Chicago/Turabian Style

Van der Does, Anne M., Gimano D. Amatngalim, Bart Keijser, Pieter S. Hiemstra, and Remi Villenave. 2018. "Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases" Vaccines 6, no. 3: 49. https://doi.org/10.3390/vaccines6030049

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop